Profile Core value Main business Legitimacy Social Responsibility
                          Patents Research Direction Technology Strength
                        API Intermediates Side chain for Paclitaxel and Docetaxel N-1 stage
                        Production management QC Quality System branch factory
                       
                      logn  

                      username:

                       password:

                       

                        home
                       
                        Products Center
                        API
                      Paclitaxel (Semi-synthetic)
                      Paclitaxel (Natural)
                      Docetaxel Anhydrous
                      Docetaxel Trihydrate
                      Cabazitaxel
                      Irinotecan HCl Trihydrate 99.5%
                      Etoposide USP31
                      Palonosetron Hydrochloride
                        N-1 stage of Paclitaxel and Docetaxel
                      7-Troc-Paclitaxel
                      7,10-di-Troc-Docetaxel
                      more...
                        Main Intermediates
                      10-Deacetylbaccatin III
                      Baccatin III
                      more...
                        Side chain for Paclixel semi-Synthetic
                      (4S,5R)-3-(N-benzoyl)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid
                        Side chain of Docetaxel
                      (4S,5R)-3-(N-tert-butoxycarbony)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid
                        Side chain for Paclitaxel and Docetaxel
                      (3R,4S)-3-hydroxy-4-phenyl-2-azetidinone
                      Ethyl (2R,3S)-3-Phenylisoserine Ester
                      more...
                       
                      Your location:Home>>R & D>>Technology Strength
                       
                       



                      Our R&D center is located in Central Shanghai, currently equipped with 18 R&D professionals and a full set of experimental equipments.

                      In the high-tech industry, technology innovation is the primary driven force and source strength for the company's continuous development. The company centers on innovation, aims at the internationally advanced, domestical blank and continuable projects, deeply committed in research and development. By taking in full consideration of reasonable arrangement for short term and long term projects, it is able to complement the basic research and the applicable development, maintain its leading position in the R&D of Anti-cancer APIs and its relevant products.



                       
                       
                      CopyRight(C)2006,Shanghai Jinhe Bio-Pharmaceutical Co.,Ltd. All Rights Reserved. Supported by ChemNet ChinaChemNet Toocle Copyright Notice ChemNet
                      HOME About us Products R & D Production and QA Contact us CHINESE
                      午夜乱伦_中文字幕无码在线观看_非洲黑人一级毛片免费观看_本道综合精品